And there's this from Gary Pruden and the folks at Ethicon...
Gary Pruden, chairman of J&J’s global surgery group, but is also working on its own version of a robot-assisted surgical platform.
"We’re early, but we have some plans that we’re moving forward with," Pruden said today. "There are opportunities not just for lower costs, but improvements in functionality, ease of use and movement within the OR."
"There’s a lot of unmet need based on the current model of robotics," added Ethicon chairman Michael del Prado, who stressed that the cost/benefit analysis for certain laparoscopy procedures like cholecystectomy might rule out robotics for those surgeries.
These are "echoes" of Titan management over the past couple of years!
News 
Market Data 
Discover 
